Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05829629
Status:
RECRUITING
Last Update Posted:
2023-09-14
First Post:
2023-04-11
Brief Title:
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Sponsor:
BlueSky Immunotherapies GmbH
Organization:
BlueSky Immunotherapies GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HPV-Related Cervical Carcinoma |
| HPV Infection |
Keywords: